Pair Name | Thymoquinone, TNF-related apoptosis inducing ligand | ||
Phytochemical Name | Thymoquinone (PubChem CID: 10281 ) | ||
Anticancer drug Name | TNF-related apoptosis inducing ligand (PubChem CID: / ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Thymoquinone, TNF-related apoptosis inducing ligand | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Biological Phenomena | Induction-->ROS-mediated apoptosis | |||
Gene Regulation | Down-regulation | Expression | BCL2 | hsa596 |
Up-regulation | Expression | CASP8 | hsa841 | |
Up-regulation | Expression | ROS1 | hsa6098 | |
Up-regulation | Expression | TNFRSF10A | hsa8797 | |
Up-regulation | Expression | TNFRSF10B | hsa8795 | |
In Vitro Model | MDA-MB-231 | Breast adenocarcinoma | Homo sapiens (Human) | CVCL_0062 |
MCF-7 | Invasive breast carcinoma of no special type | Homo sapiens (Human) | CVCL_0031 | |
Result | The synergistic influence between TQ which induced the DR5 and TRAIL, facilitating the connection between TRAIL and its receptors on the cancerous cell membrane. Hence, the proposed combination therapy induced the ROS-mediated apoptotic stimulus. |
No. | Title | Href |
---|---|---|
1 | Thymoquinone Crosstalks with DR5 to Sensitize TRAIL Resistance and Stimulate ROS-Mediated Cancer Apoptosis. Asian Pac J Cancer Prev. 2021 Sep 1;22(9):2855-2865. doi: 10.31557/APJCP.2021.22.9.2855. | Click |